All > Healthcare > Medicine > Cancer

• (… MAH-noh-KLOH-nul AN-tih-BAH-dee …) A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to the protein MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate.

  National Cancer Institute - Cite This Source - This Definition
  ×

  Cite Definition for 2IT-BAD monoclonal antibody 170

  American Psychological Association (APA)

  2IT-BAD monoclonal antibody 170. (n.d.). Dictionary of Cancer Terms. Retrieved June 8, 2023, from website: http://www.expertglossary.com/definition/2it-bad-monoclonal-antibody-170.

  Chicago Manual of Style (CMS)

  2IT-BAD monoclonal antibody 170. www.cancer.gov. Dictionary of Cancer Terms. National Cancer Institute. http://www.expertglossary.com/definition/2it-bad-monoclonal-antibody-170 (accessed: June 8, 2023).

  Modern Language Association (MLA)

  "2IT-BAD monoclonal antibody 170." Dictionary of Cancer Terms. National Cancer Institute. 8 June. 2023 http://www.expertglossary.com/definition/2it-bad-monoclonal-antibody-170.

• Browse Related Terms: 2IT-BAD monoclonal antibody 170, 90Y-DOTA-biotin, capromab pendetide, CC49-streptavidin, indium In 111 DOTA monoclonal antibody HuAFP31, ProstaScint, ProstaScint scan, streptavidin, yttrium Y 90, yttrium Y 90 DOTA monoclonal antibody HuAFP31, yttrium Y 90 DOTA monoclonal antibody HuPAM4, yttrium Y 90 DOTA-biotin